Evofem Biosciences, Inc.
EVFM · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Zhang Yan: Form 4
Insider disclosure · Filed · Report period 12 Jan 2024
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001618835 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- EVFM on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 12400 High Bluff Drive, Suite 600, San Diego, CA, 92130
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Neothetics, Inc. (to 05 Jan 2018)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields